New Challenges in Cardiovascular Diseases: From Molecular Pathogenesis to Therapeutic Approaches
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Molecular Targeted Therapy".
Deadline for manuscript submissions: closed (25 April 2024) | Viewed by 125
Special Issue Editor
2. Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan
Interests: heart failure; hypertension; cardiology; cardiovascular medicine
Special Issue Information
Dear Colleagues,
Cardiovascular diseases (CVDs), a major cause of mortality in humans, have a complex etiology. Multiple risk factors and pathological mechanisms contribute to this disease.
We need a deeper understanding of the molecular pathogenesis underlying cardiovascular disease. Although we already know some basic information, we need a more detailed understanding in order to find better treatments. For example, we must increase our understanding of metabolic and signaling pathways in the human body, and their relationship to cardiovascular disease. We also need to study interactions between genes and environmental factors, and how they influence the onset and progression of cardiovascular disease.
In addition, we need novel treatments. Although cardiovascular disease has long been a focus of research, new and innovative ideas are necessary. For example, we can study the effects of new treatments such as gene therapy, cell therapy and stem cell therapy. We can also explore some non-drug treatments.
This Special Issue of the Journal of Personalized Medicine aims to highlight some of the latest studies in the field of cardiovascular diseases, especially relating molecular pathogenesis to therapeutic approaches.
Prof. Dr. Pao-Hsien Chu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular diseases (CVDs)
- heart failure
- hypertension
- molecular pathogenesis
- therapeutic approaches
- metabolic and signaling pathways
- genes and environmental factors
